Location History:
- Walsall, GB (2003 - 2007)
- Bicester, GB (2006 - 2008)
- Oxford, GB (2007 - 2012)
Company Filing History:
10 out of 2,538 
7 out of 16 
5 out of 4,455 
Years Active: 2003-2012
Title: Martin James Procter: Innovator in Metabolic Disorder Treatments
Introduction
Martin James Procter is a prominent inventor based in Oxford, GB, known for his impactful contributions to the field of pharmaceuticals, especially in the treatment of metabolic disorders. With a total of 24 patents to his name, Procter has been at the forefront of innovation, developing compounds that target critical health issues such as obesity and diabetes.
Latest Patents
Among Procter's notable recent patents are "Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders," which focuses on compounds that act as opioid receptor modulators. These compounds are particularly significant as mu-opioid receptor antagonists, neutral antagonists, or inverse agonists, offering potential treatment options for obesity. Another key patent is for "Heterocyclic derivatives as GPCR receptor agonists," which details compounds that are agonists of GPR116. These agonists are valuable for regulating satiety and can be beneficial in addressing both obesity and diabetes.
Career Highlights
Procter's career includes significant roles at notable companies, including Warner-Lambert Company and Prosidion Limited. His expertise in pharmaceutical innovation has propelled advancements in the field, reflecting both his dedication and the impact of his work on public health.
Collaborations
Throughout his career, Procter has collaborated with esteemed colleagues such as Karen Lesley Schofield and Stuart Edward Bradley. These partnerships have fostered a collaborative environment for research and development, enhancing the efficacy and reach of their innovative solutions.
Conclusion
Martin James Procter's contributions to the pharmaceutical industry underscore his role as an influential inventor in the realm of metabolic disorder treatments. With a strong portfolio of patents and a commitment to addressing critical health challenges, Procter continues to impact the scientific community and improve the lives of those affected by metabolic disorders.